Johnson & Johnson's niraparib combo significantly delays prostate cancer progression in HRR-altered patients with strong ...

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Johnson & Johnson (NYSE:JNJ) recently announced promising Phase 1 study results for Pasritamig, a novel antibody for advanced ...

JNJ-79635322 shows favorable responses and manageable safety in BCMA/GPRC5D-naïve patients with relapsed/refractory multiple ...

Shares with over 50 years of consecutive dividend increases rarely go under the radar. But that might be what’s happening ...

Johnson & Johnson (JNJ) posts Phase 3 trial win for Akkega plus prednisone in metastatic castration-sensitive prostate cancer ...

AnaptysBio (ANAB) stock dips as rival J&J's (JNJ) trial data for its anti-inflammatory agent similar to ANAB's lead asset ...

Dr. Jared Weiss details the importance of continued research into novel therapies for patients with lung cancer.

Johnson & Johnson shared positive ASCO 2025 results, including improved survival and remission in prostate and multiple ...

The best way to navigate the current market uncertainty is to invest in stocks that have seen the ups and downs and thrived ...

Ever since I started my investment journey, dividend stocks have remained a favorite, and for good reason. I enjoy the steady ...

Jerina Vincent and her daughter Natania Julius burst into laughter and embraced. “Mom!” Julius said through an incredulous ...